Dr. Lee Richstone
Overview
Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco.
Dr. Richstone is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
His clinical research consists of co-authoring 70 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
130 East 77th Street, Black Hall, 5th Floor, New York, NY 10075
110 East 58th Street, 10th Floor, New York, NY 10022
Additional Areas of Focus
Dr. Richstone has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Solid Tumor Group
Darren Feldman is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Feldman is rated as an Elite provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy.
Memorial Solid Tumor Group
Samuel Funt is an Oncologist in New York, New York. Dr. Funt is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Urothelial Cancer, Testicular Cancer, Teratoma of the Mediastinum, Bladder Cancer, and Orchiectomy.
Kai Tsao, MD, MS, is the system chief of solid tumor oncology, medical director of the R.J. Zuckerberg Cancer Center, and medical director of the medical oncology prostate cancer program at the Northwell Cancer Institute. He specializes in cancers of the genitourinary organs and has more than a decade of clinical experience. His research focuses on the development of biomarkers and novel therapies for patients with genitourinary cancers.Dr. Tsao was inspired to become an oncologist after witnessing many close family and friends suffering from cancer. He completed medical school training at SUNY Downstate, an internal medicine residency at Long Island Jewish Medical Center, and a fellowship in hematology and medical oncology at Mount Sinai Hospital. He earned a master's degree in healthcare delivery leadership at Icahn School of Medicine at Mount Sinai and completed Lean Six Sigma training at Johns Hopkins.Prior to joining Northwell, Dr. Tsao served as medical director of the Ruttenberg Treatment Center, medical director of the medical oncology prostate cancer program, and physician leader for internal oncology collaborations at the Mount Sinai Hospital, Tisch Cancer Institute. In these roles, Dr. Tsao and his team built a cancer center that is patient centered, quality driven, scientifically innovative, and provided multi-disciplinary care to patients with cancer.For me, patient care much more than the cancer diagnosis and treatment. It is essential to address the many needs of our cancer patients: emotional well-being, social support, nutrition, physical activity, financial challenges and more. We aim to provide the best support for our patients, one at a time.Dr. Tsao is an accomplished physician-scientist who has authored more than 80 peer-reviewed publications in the field of genitourinary oncology. He serves as associate editor of Genitourinary Oncology, Frontiers in Oncology. His leadership in carrying out complex clinical trials in targeted therapies and immunotherapies positions his patients at the forefront of cutting-edge cancer research and patient-centered care.What I most enjoy every day is seeing patients under our care, despite the devastation of their cancer diagnosis, beating their cancer and living a life that was not considered a possibility years ago. Our mission at Northwell Cancer Institute is to make this a reality for every single patient. Dr. Tsao is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Orchiectomy, and Nephrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Richstone isDistinguished. Learn about Bladder Cancer.
- CystectomyDr. Richstone isDistinguished. Learn about Cystectomy.
- Enlarged Prostate (BPH)Dr. Richstone isDistinguished. Learn about Enlarged Prostate (BPH).
- Muscle Invasive Bladder CancerDr. Richstone isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- NephrectomyDr. Richstone isDistinguished. Learn about Nephrectomy.
- Non-Muscle Invasive Bladder CancerDr. Richstone isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Advanced
- Bilateral HydronephrosisDr. Richstone isAdvanced. Learn about Bilateral Hydronephrosis.
- Chromophobe Renal Cell CarcinomaDr. Richstone isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Richstone isAdvanced. Learn about Clear Cell Sarcoma.
- EndoscopyDr. Richstone isAdvanced. Learn about Endoscopy.
- Familial Prostate CancerDr. Richstone isAdvanced. Learn about Familial Prostate Cancer.
- Familial Wilms Tumor 2Dr. Richstone isAdvanced. Learn about Familial Wilms Tumor 2.
- Experienced
- Bladder Outlet ObstructionDr. Richstone isExperienced. Learn about Bladder Outlet Obstruction.
- Bladder StonesDr. Richstone isExperienced. Learn about Bladder Stones.
- BoilsDr. Richstone isExperienced. Learn about Boils.
- CarbuncleDr. Richstone isExperienced. Learn about Carbuncle.
- ChoriocarcinomaDr. Richstone isExperienced. Learn about Choriocarcinoma.
- EmpyemaDr. Richstone isExperienced. Learn about Empyema.